Arizzer Pharmaceuticals Private Limited

Arizzer Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. Directors, charges & compliance details.
CIN U51909MH2022PTC380228 Incorporated 09 April 2022 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹2.11 Cr
▲ 31% YoY
Net profit · FY 2024
₹2.14 Lakh
Net margin 1%
EBITDA · FY 2024
₹4.16 Lakh
EBITDA margin 2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Arizzer Pharmaceuticals Private Limited

Data last updated:

Arizzer Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 April 2022.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2022PTC380228.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kavita Jain and Ramesh Nathmal Jain.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 8 Floor – 1 Plot 170/172 Amarchand Kalyanji Kika Street Gulalwadi Girgaon, Mumbai, Maharashtra, India – 400004.

As per the financials filed for FY 2024, the company reported a revenue of ₹2.11 Cr, a growth of 31% compared to the previous year. For the same year it recorded a net profit of ₹2.14 Lakh (net margin 1%) and EBITDA of ₹4.16 Lakh (EBITDA margin 2%).

Company details

CIN U51909MH2022PTC380228
Registration Number 380228
Incorporation Date 09 April 2022
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025

Contact details

Arizzer Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra.

  • Registered Address
    8 Floor – 1 Plot 170/172 Amarchand Kalyanji Kika Street Gulalwadi Girgaon, Mumbai, Maharashtra, India – 400004
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Arizzer Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Arizzer Pharmaceuticals is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Arizzer Pharmaceuticals Private Limited, buy the company report.

Financials of Arizzer Pharmaceuticals Private Limited

FY 2025 filings available

Arizzer Pharmaceuticals Private Limited reported revenue of ₹2.11 Cr (up 31% YoY) for FY 2024.

Revenue · FY 2024
₹2.11 Cr ▲ 31%
Net profit · FY 2024
₹2.14 Lakh margin 1%
EBITDA · FY 2024
₹4.16 Lakh margin 2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 31%
EBITDA CAGR growth
1 year
▲ 19%

Revenue rose 31% in the latest year. EBITDA rose 19% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹4.16 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹2.14 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23
Profitability
EBITDA Margin2%
Net Profit Margin1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Arizzer Pharmaceuticals Private Limited, buy the company report.

Board of directors of Arizzer Pharmaceuticals Private Limited

Arizzer Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Kavita JainDirector09 Apr 20224 Years 6 MonthsCurrent
Ramesh Nathmal JainDirector09 Apr 20224 Years 6 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Arizzer Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Arizzer Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Arizzer Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Kavita Jain was appointed as Director on 09 Apr 2022.

AGM
Arizzer Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Arizzer Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Kavita Jain was appointed as Director.
Appointed
Ramesh Nathmal Jain was appointed as Director.
Incorporation
09 Apr 2022
Arizzer Pharmaceuticals Private Limited was registered on 09 Apr 2022 with Roc Mumbai & aged 4 years 6 months as per MCA records.

Frequently asked questions

Arizzer Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 April 2022 (4+ years old) and is registered under CIN U51909MH2022PTC380228.

Arizzer Pharmaceuticals has 2 current directors:

The latest financial statements of Arizzer Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.

The CIN (Corporate Identification Number) of Arizzer Pharmaceuticals is U51909MH2022PTC380228. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Arizzer Pharmaceuticals was incorporated on 09 April 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.

Kavita Jain was appointed as Director on 09 Apr 2022. Ramesh Nathmal Jain was appointed as Director on 09 Apr 2022.

The registered office of Arizzer Pharmaceuticals is at 8 Floor – 1 Plot 170172 Amarchand Kalyanji Kika Street Gulalwadi Girgaon, Mumbai, Maharashtra, India – 400004.

Arizzer Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

Arizzer Pharmaceuticals can be reached at its registered office: 8 Floor – 1 Plot 170172 Amarchand Kalyanji Kika Street Gulalwadi Girgaon, Mumbai, Maharashtra, India – 400004.

Arizzer Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.